Alliance funds 19 Research Challenge Awards looking for answers on progression

27th May 2021

In time for World MS Day, €1,425,000 has been awarded to help identify new therapeutic targets in…

How do different DMTs affect people’s COVID-19 vaccine response?

15th May 2021

Researchers in Israel have published the results of a small study exploring how well the Pfizer-BioNtech COVID-19…

Join the movement to stop MS this World Brain Day

15th May 2021

Save the date – World Brain Day is on 22 July 2021

MS and depression – testing the relationship

15th May 2021

This article delves into the land of genetics, explaining the method called ‘Mendelian randomisation’, which scientists use…

The Atlas of MS part 2 is live!

27th April 2021

The clinical management part of the Atlas of MS is now available

Catch up on the latest breakthroughs in progressive MS treatments

16th April 2021

A first-of-its-kind global research network funded by the International Progressive MS Alliance aims to develop new, effective…

Celebrating the Spanish language in the global MSIF movement

16th April 2021

April 23 is World Spanish Language Day

What is a biomarker?

16th April 2021

Biomarkers is a term that often comes up when we talk about MS treatment and clinical trials…

A stronger movement with ARSEP

16th April 2021

The Fondation pour l’Aide à la Recherche sur la Sclérose En Plaques (ARSEP) joins MSIF, marking a…

Call for consultants: Capacity building evaluation – Latin America

22nd March 2021

We are seeking an experienced consultant to contribute to the evaluation and analysis of MSIF’s regional strategies…

Celebrating World French Language Day

15th March 2021

Showcasing MS resources ‘en français’ on World French Language Day

Making information on MS fatigue accessible to all

26th February 2021

Translating and adapting Fatigue: an invisible symptom of MS.